Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS
Applications | 2021 | Agilent TechnologiesInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, 2D-LC, GPC/SEC
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Key wordsdimension, dar, adcs, adc, second, native, hic, advancebio, counts, mab, deconvoluted, drug, first, conjugated, intact, denatured, file, characterization, amu, agilent, solvent, various, were, brentuximab, vedotin, spectrum, mass, mhc, antibody, column, masshunter, under, jet, desalting, conjugates, cysteine, dars, molecule, acquisition, together, thermostat, stream, separation, values, determination, new, data, splits, sec, mabs
Similar PDF
Characterization of Antibody Drug Conjugates (ADC) using 2-Dimension Liquid Chromatography (2D-LC) and Native Mass Spectrometric Technologies
2021|Agilent Technologies|Posters
Poster Reprint ASMS 2021 Poster number ThP003 Characterization of Antibody-Drug Conjugates (ADC) using 2-Dimension Liquid Chromatography (2D-LC) and Native Mass Spectrometric Technologies David L. Wong and Sarah M. Stow Agilent Technologies, Inc., Santa Clara, CA, USA Introduction Antibody drug conjugates…
Key words
drug, drughic, hicadc, adcantibody, antibodyadvancebio, advancebiodar, darmab, mabintact, intactconjugates, conjugatesbrentuximab, brentuximabvedotin, vedotinnative, nativeconjugated, conjugatedspectrometric, spectrometrichydrophobic
Drug to Antibody Ratio Analysis of Brentuximab Vedotin in Monkey Plasma
2024|Agilent Technologies|Applications
Application Note Biotherapeutics & Biosimilars Drug to Antibody Ratio Analysis of Brentuximab Vedotin in Monkey Plasma Antibody drug conjugate analysis under native conditions using Agilent AdvanceBio 6545XT LC/Q-TOF systems Authors Xi Qiu and Kenda LJ Evans Agilent Technologies, Inc. Andrea…
Key words
brentuximab, brentuximabdar, darmonkey, monkeylba, lbaadc, adcamu, amudeconvoluted, deconvoluteddrug, drugcounts, countsadcs, adcsnative, nativeantibody, antibodyassaymap, assaymapagilent, agilentbravo
Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods
2024|Agilent Technologies|Guides
Consumables Workflow Ordering Guide Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods Antibody Drug Conjugates Antibody-drug conjugates (ADCs) represent a new generation of targeted biotherapeutics that make up a rapidly growing segment of the drug discovery pipeline.…
Key words
mylist, mylistcysteine, cysteinedar, daradc, adcadcs, adcslysine, lysinelinker, linkercolumn, columnhic, hicauristatin, auristatinvedotin, vedotinantibody, antibodymmae, mmaeintact, intactinfinitylab
High Salt—High Reproducibility - Analysis of antibody drug conjugates using hydrophobic interaction chromatography with the Agilent 1290 Infinity II Bio LC System
2020|Agilent Technologies|Applications
Application Note Biopharma High Salt—High Reproducibility Analysis of antibody drug conjugates using hydrophobic interaction chromatography with the Agilent 1290 Infinity II Bio LC System Response (mAU) ×101 D2 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 1.4 1.2…
Key words
dar, darhic, hicbrentuximab, brentuximabvedotin, vedotinantibody, antibodydrug, drugsubtraction, subtractionbiocompatible, biocompatiblearea, areaadc, adcsalt, saltmolecules, moleculesprecision, precisionmau, mauspecies